Good laboratory practice (GLP) facilities: risk-based quality assurance

Law Healthcare & Pharma Guidance

Date: 29th Nov, 2024 Source: Medicines and Healthcare products Regulatory Agency (MHRA) Country: United Kingdom Original Source

Brief

The document provides guidance on risk-based quality assurance programs under the Good Laboratory Practice (GLP) framework. It covers the risk assessment lifecycle and different types of inspections, including safety tests for chemicals. The guidance also addresses the implications of COVID-19 for GLP facilities.

This content is restricted.

Highlights content goes here...

This content is restricted.

Medicines and Healthcare products Regulatory Agency (MHRA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Good laboratory practice (GLP) facilities: risk-based quality assurance

Brief

Medicines and Healthcare products Regulatory Agency (MHRA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Good laboratory practice (GLP) facilities: risk-based quality assurance

Brief

Medicines and Healthcare products Regulatory Agency (MHRA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.